Natural history of papillomavirus infections;Histoire naturelle des infections à papillomavirus

Revue du Praticien

Volumn 56, Issue 17, 2006, Pages 1883-1889

  Mougin, Christiane ^a   Mo, Lingzhao ^a   Dalstein, Véronique ^b  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; DNA INTEGRATION; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; NONHUMAN; REVIEW; RISK ASSESSMENT; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL DYSPLASIA;

EID: 33845318545     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Richart RM. Cervical intraepithelial neoplasia. Pathol Annu 1973;8:301-28.
2. Colgan TJ, Lickrish GM. The topography and invasive potential of cervical adenocarcinoma in situ, with and without associated squamous dysplasia. Gynecol Oncol 1990;36:246-9.
3. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
4. Kjaer SK, Chackerian B, van den Brule AJ, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001;10:101-6.
5. Munoz N, Castellsague X, Bosch FX, et al. Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. J Natl Cancer Inst 1996;88:1068-75.
6. Winer RL, Hughes JP, Feng O, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006;354:2645-54.
7. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
8. Dalstein V, Riethmuller D, Prétet JL, et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003;106:396-403.
9. Villa LL, Sichero L, Rahal P, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000;81:2959-68.
10. Monnier-Benoit S, Dalstein V, Riethmuller D, Lalaoui N, Mougin C, Prétet JL. Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions. J Clin Virol 2006;35:270-7.
11. Kulmala SM, Syrjanen SM, Gyllensten UB, et al. Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 2006;59:513-7.
12. Greslin I, Mougin C, Seilles E. Biologie des infections à papillomavirus. III. Reponse immunitaire. Ann Biol Clin 1998;56:267-76.
13. Moodley M, Moodley J, Chetty R, Herrington CS. The role of steroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review. Int J Gynecol Cancer 2003;13:103-10.
14. Woodman CB, Collins S, Winter H. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6.
15. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
16. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-92.
17. Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis.Obstet Gynecol 1998;92:727-35.